ArticleOncotarget2015

Rapatar, a nanoformulation of rapamycin, decreases chemically-induced benign prostate hyperplasia in rats.

Ekaterina A Lesovaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.